Literature DB >> 31396943

Using the Inducible Caspase-9 Suicide-Safeguard System with iPSC and Bioluminescent Tracking.

Jonathan Villanueva1, Toshinobu Nishimura1, Hiromitsu Nakauchi2.   

Abstract

For scientists working within the field of induced pluripotent stem cells (iPSCs), this protocol will provide a thorough walk-through on how to conduct in vitro and in vivo experiments that validate the function of a particular safeguard system technology. In short, we provide instructions on how to generate inducible Caspase-9 (iC9) safeguard system with human iPSCs that act as normal or abnormal models of the cells for therapeutics to be tried after differentiation. These iC9-iPSCs should be modified prior to beginning this protocol by constitutively expressing luciferase, an enzyme capable of generating bioluminescent signals through the oxidation of the substrate luciferin. Monitoring the bioluminescent signal over time provides the information on whether a safeguard system is working or not.

Entities:  

Keywords:  Bioluminescence; Cancer; Cytotoxicity; Immunotherapy; T cell

Mesh:

Substances:

Year:  2019        PMID: 31396943     DOI: 10.1007/978-1-4939-9728-2_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells.

Authors:  Wei Zhao; Anhua Lei; Lin Tian; Xudong Wang; Cristina Correia; Taylor Weiskittel; Hu Li; Alan Trounson; Qiuli Fu; Ke Yao; Jin Zhang
Journal:  iScience       Date:  2020-05-17

Review 2.  Enabling allogeneic therapies: CIRM-funded strategies for immune tolerance and immune evasion.

Authors:  Lisa C Kadyk; Ross M Okamura; Sohel Talib
Journal:  Stem Cells Transl Med       Date:  2020-06-25       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.